Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-15

Clinical Trial Update: Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Vincristine, Dactinomycin, and Doxorubicin with or without radiation or observation after surgery for newly diagnosed Stage I–III Wilms…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dactinomycin (dactinomycin)
  • Doxorubicin (doxorubicin)
  • Vincristine (vincristine)

Snippet

Sponsor: Children's Oncology Group | Conditions: Stage I Kidney Wilms Tumor, Stage II Kidney Wilms Tumor | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2017-05-15